the vaccine, Dana–Farber Cancer Institute

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.
Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...
The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...